Legend Biotech Reports Second Quarter 2023 Results and Recent Highlights
Aug 15, 2023
Legend Biotech to Host Investor Conference Call on Second-Quarter Results
Aug 03, 2023
Legend Biotech Announces Submission of Supplemental Application to the U.S...
Jun 06, 2023
Ciltacabtagene Autoleucel (cilta-cel) Reduced Risk of Disease Progression o..
Jun 05, 2023
Legend Biotech Announces Submission to the European Medicines Agency for Ex..
May 25, 2023